Table 2 Endoscopic retrograde cholangiopancreatography findings
DOAC group | No-drug group | p value | |
|---|---|---|---|
n = 42 (8.0%) | n = 482 (92.0%) | ||
Periampullary diverticulum | 13 (31.0%) | 134 (27.8%) | 0.72 |
Precut | 1 (2.0%) | 4 (0.8%) | 0.343 |
Lithotripsy | 33 (79.0%) | 345 (71.6%) | 0.375 |
EPLBD | 5 (12.0%) | 25 (5.2%) | 0.082 |
Metallic stent | 2 (5.0%) | 50 (10.4%) | 0.415 |
Plastic stent | 5 (12.0%) | 100 (20.7%) | 0.227 |
ENBD | 3 (7.0%) | 28 (5.8%) | 0.729 |
Complication‡ | |||
Bleeding | 6 (14.0%) | 15 (3.1%) | 0.004 |
Pancreatitis | 0 | 17 (3.5%) | 0.384 |
Perforation | 0 | 3 (0.6%) | 0.99 |
Cholecystitis | 1 (2.0%) | 5 (1.0%) | 0.396 |
Others | 0 | 4 (0.8%) | 0.99 |
Total | 7 (17.0%) | 43 (8.9%) | 0.104 |
Heparin replacement | 12 (29.0%) | 0 | < 0.001 |
APTT before EST in patients with heparin replacement | 39.6 (31.0–62.6) | ||